215 related articles for article (PubMed ID: 34532282)
1. Inhibition of MIR4435-2HG on Invasion, Migration, and EMT of Gastric Carcinoma Cells by Mediating MiR-138-5p/Sox4 Axis.
Gao LF; Li W; Liu YG; Zhang C; Gao WN; Wang L
Front Oncol; 2021; 11():661288. PubMed ID: 34532282
[TBL] [Abstract][Full Text] [Related]
2. LncRNA MIR4435-2HG promotes proliferation, migration, invasion and epithelial mesenchymal transition via targeting miR-22-3p/TMEM9B in breast cancer.
Ke J; Wang Q; Zhang W; Ni S; Mei H
Am J Transl Res; 2022; 14(8):5441-5454. PubMed ID: 36105009
[TBL] [Abstract][Full Text] [Related]
3. MIR4435-2HG, miR-125b-5p, and Sema4D axis affects the aggressiveness of colorectal cancer cells.
Yu M; Yi Z; Chen S; Chen X; Xie X
Folia Histochem Cytobiol; 2022; 60(2):191-202. PubMed ID: 35730423
[TBL] [Abstract][Full Text] [Related]
4. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
[TBL] [Abstract][Full Text] [Related]
5. lncRNA MIR4435-2HG promoted clear cell renal cell carcinoma malignant progression via miR-513a-5p/KLF6 axis.
Zhu K; Miao C; Tian Y; Qin Z; Xue J; Xia J; Zhu S; Xu A; Yang J; Wang Z
J Cell Mol Med; 2020 Sep; 24(17):10013-10026. PubMed ID: 33460239
[TBL] [Abstract][Full Text] [Related]
6. LncRNA MIR4435-2HG drives cancer progression by modulating cell cycle regulators and mTOR signaling in stroma-enriched subtypes of urothelial carcinoma of the bladder.
Pei L; Yan D; He Q; Kong J; Yang M; Ruan H; Lin Q; Huang L; Huang J; Lin T; Qin H
Cell Oncol (Dordr); 2023 Oct; 46(5):1509-1527. PubMed ID: 37355516
[TBL] [Abstract][Full Text] [Related]
7. Long Non-coding RNA MIR4435-2HG Promotes Colorectal Cancer Proliferation and Metastasis Through miR-206/YAP1 Axis.
Dong X; Yang Z; Yang H; Li D; Qiu X
Front Oncol; 2020; 10():160. PubMed ID: 32154166
[No Abstract] [Full Text] [Related]
8. Knockdown of MIR4435-2HG Suppresses the Proliferation, Migration and Invasion of Cervical Cancer Cells via Regulating the miR-128-3p/MSI2 Axis in vitro.
Wang R; Liu L; Jiao J; Gao D
Cancer Manag Res; 2020; 12():8745-8756. PubMed ID: 33061572
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA MIR4435-2HG/microRNA-125a-5p axis is involved in myocardial ischemic injuries.
Wang X; Ren L; Chen S; Tao Y; Zhao D; Wu C
Bioengineered; 2022 Apr; 13(4):10707-10720. PubMed ID: 35475469
[TBL] [Abstract][Full Text] [Related]
10. Fusobacterium nucleatum promotes epithelial-mesenchymal transiton through regulation of the lncRNA MIR4435-2HG/miR-296-5p/Akt2/SNAI1 signaling pathway.
Zhang S; Li C; Liu J; Geng F; Shi X; Li Q; Lu Z; Pan Y
FEBS J; 2020 Sep; 287(18):4032-4047. PubMed ID: 31997506
[TBL] [Abstract][Full Text] [Related]
11. LncRNA MIR4435-2HG triggers ovarian cancer progression by regulating miR-128-3p/CKD14 axis.
Zhu L; Wang A; Gao M; Duan X; Li Z
Cancer Cell Int; 2020; 20():145. PubMed ID: 32377170
[TBL] [Abstract][Full Text] [Related]
12. LncRNA MIR4435-2HG functions as a ceRNA against miR-125a-5p and promotes neuroglioma development by upregulating TAZ.
Shen W; Zhang J; Pan Y; Jin Y
J Clin Lab Anal; 2021 Dec; 35(12):e24066. PubMed ID: 34714963
[TBL] [Abstract][Full Text] [Related]
13. LncRNA MIR4435-2HG targets desmoplakin and promotes growth and metastasis of gastric cancer by activating Wnt/β-catenin signaling.
Wang H; Wu M; Lu Y; He K; Cai X; Yu X; Lu J; Teng L
Aging (Albany NY); 2019 Sep; 11(17):6657-6673. PubMed ID: 31484163
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA MIR4435-2HG recruits miR-802 from FLOT2 to promote melanoma progression.
Ma DM; Sun D; Wang J; Jin DH; Li Y; Han YE
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(5):2616-2624. PubMed ID: 32196611
[TBL] [Abstract][Full Text] [Related]
15. LncRNA TDRG1 promotes the proliferation, migration, and invasion of cervical cancer cells by sponging miR-214-5p to target SOX4.
Guo M; Lin B; Li G; Lin J; Jiang X
J Recept Signal Transduct Res; 2020 Jun; 40(3):281-293. PubMed ID: 32106739
[TBL] [Abstract][Full Text] [Related]
16. LINC01305 inhibits malignant progression of cervical cancer via miR-129-5p/Sox4 axis.
Xu Y; Zhu H; Ma H; Yuan L; Hu Q; Yang L
Am J Transl Res; 2020; 12(11):7581-7592. PubMed ID: 33312390
[TBL] [Abstract][Full Text] [Related]
17. lncRNA MIR4435-2HG Accelerates the Development of Bladder Cancer through Enhancing IQGAP3 and CDCA5 Expression.
Yang T; Li Y; Wang G; Guo L; Sun F; Li S; Deng X; Liu J
Biomed Res Int; 2022; 2022():3858249. PubMed ID: 35993042
[TBL] [Abstract][Full Text] [Related]
18. LncRNA MIR4435-2HG contributes into colorectal cancer development and predicts poor prognosis.
Shen MY; Zhou GR; -Y Zhang Z
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(4):1771-1777. PubMed ID: 32141545
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive analysis of the MIR4435-2HG/miR-1-3p/MMP9/miR-29-3p/DUXAP8 ceRNA network axis in hepatocellular carcinoma.
Zhang L; Hu S; Chen J; Ma S; Liu F; Liu C; Gao Y
Discov Oncol; 2021 Oct; 12(1):38. PubMed ID: 35201491
[TBL] [Abstract][Full Text] [Related]
20. MIR4435-2HG: A Tumor-associated Long Non-coding RNA.
Zhao F; Liu Y; Tan F; Tang L; Du Z; Mou J; Zhou G; Yuan C
Curr Pharm Des; 2022; 28(25):2043-2051. PubMed ID: 35674305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]